Results 251 to 260 of about 36,666 (331)

Effect of Cold Adaptation on the State of Cardiovascular System and Cardiac Tolerance to Ischemia/Reperfusion Injury. [PDF]

open access: yesIran Biomed J
Voronkov NS   +8 more
europepmc   +1 more source

Increased plasma levels of the novel vasoconstrictor peptide endothelin in severe pre-eclampsia

open access: bronze, 1991
Gustaaf Dekker   +3 more
openalex   +1 more source

Nonsense Mutations in Rare and Ultra‐Rare Human Disorders: An Overview

open access: yesIUBMB Life, Volume 77, Issue 6, June 2025.
ABSTRACT Over 7000 rare diseases have been described, collectively affecting 350 million people worldwide. Most of these conditions result from nonsense mutations, representing approximately 10% of all genetic mutations associated with human inherited diseases.
Emanuele Vitale   +8 more
wiley   +1 more source

Do we need endothelin antagonists? [PDF]

open access: yes, 2017
Lüscher, Thomas F.
core  

Ferulic acid: extraction, estimation, bioactivity and applications for human health and food

open access: yesJournal of the Science of Food and Agriculture, Volume 105, Issue 8, Page 4168-4177, June 2025.
Abstract Ferulic acid ((E)‐3‐(4‐hydroxy‐3‐methoxy‐phenyl) prop‐2‐enoic acid) is a derivative of caffeic acid found in most plants. This abundant phenolic compound exhibits significant antioxidant capacity and a broad spectrum of therapeutic effects, including anti‐inflammatory, antimicrobial, anticancer, antidiabetic, cardiovascular and neuroprotective
Mukul Kumar   +13 more
wiley   +1 more source

Aprocitentan in hypertension management: clinical efficacy, safety, and future prospects. [PDF]

open access: yesAnn Med Surg (Lond)
Riaz R   +6 more
europepmc   +1 more source

Aselacins, novel compounds that inhibit binding of endothelin to its receptor. II. Isolation and elucidation of structures.

open access: bronze, 1994
Jill E. Hochlowski   +6 more
openalex   +2 more sources

New Mechanisms and Therapeutic Targets in Systemic Lupus Erythematosus

open access: yesMedComm, Volume 6, Issue 6, June 2025.
Systemic lupus erythematosus (SLE) is a multiple organ involved autoimmune disorder with heterogeneous clinical manifestations. Despite hallmark features such as elevated type I interferon and the production of numerous autoantibodies, the underlying pathogenic mechanisms remain elusive.
Jingru Tian   +4 more
wiley   +1 more source

Aselacins, novel compounds that inhibit binding of endothelin to its receptor. I. The producing organism, fermentation and biological activity.

open access: bronze, 1994
MARIANNA JACKSON   +6 more
openalex   +2 more sources

Home - About - Disclaimer - Privacy